Fortress Biotech Inc stock is traded at $2.01, with a volume of 382,209. It is up +5.24% in the last 24 hours and down -4.74% over the past month. Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
Previous Close:
$1.91
Open:
$1.94
24h Volume:
382,209
Relative Volume:
1.83
Market Cap:
$67.04M
Revenue:
$66.16M
Net Income/Loss:
$128.94M
P/E Ratio:
0.63
EPS:
$3.18
Net Cash Flow:
$152.08M
1W Performance:
+9.24%
1M Performance:
-4.74%
6M Performance:
-11.06%
1Y Performance:
-23.28%
1-Day Range:
$1.93$2.04
1-Week Range:
$1.82$2.04
52-Week Range:
$1.79$4.53
Fortress Biotech Inc Stock (FBIO) Company Profile
Name
Fortress Biotech IncSector
HealthcareIndustry
BiotechnologyPhone
781-652-4500Address
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS